Visionbody by VB TECH: Engineering Strength for Longevity

A Technology Report Based on the Founders’ Vision of Wireless EMS/EMA Wellness Systems

By: Lennard M. Goetze, Ed.D (HealthTech Reporter)

Visionbody by VB TECH was not conceived as a fitness shortcut. It emerged from a long-standing frustration with how electrostimulation had been commercialized—bulky wired systems, awkward studio setups, and a narrative that reduced EMS to a novelty for people who “don’t want to go to the gym.” Krisztina Schmidt, co-founder of VB TECH, describes their original motivation plainly: “We just simply believed in EMS on a higher level than the others using it… it shouldn’t be like this.”

That belief pushed Krisztina and her husband, Henri Schmidt, to pursue a wireless, intelligent, full-body system that could deliver serious neuromuscular stimulation without the friction of wires, bulky hardware, or narrow use cases. Their goal was not to invent electrotherapy from scratch, but to elevate it through engineering. As Krisztina notes, “We didn’t invent low- and middle-frequency modulated electrotherapy… this is used in rehab for a long time, especially in Europe.”

The innovation, in their view, was building a platform that could translate clinical-grade principles into a consumer-accessible, safety-validated system.

 

From Clinical Roots to Consumer Engineering

Krisztina’s background working alongside rehabilitation specialists—and even veterinary clinicians using frequency protocols for horses and dogs—shaped Visionbody’s early design logic. The founders learned that outcomes depend less on the presence of electricity and more on how intelligently frequencies are modulated and applied. Over a decade of development culminated in Visionbody’s first commercial release in 2014. Regulatory milestones followed, including FDA clearance and TÜV safety certification. Krisztina underscores the rigor of their quality standards: “They really take the product into tiny pieces and check every component… it’s protecting the consumers.”

From the outset, VB TECH chose to position Visionbody as a fitness-cleared platform rather than a prescription-only medical device, to avoid limiting access while still operating within regulatory guardrails. The founders’ strategy reflects a pragmatic balance: build with clinical seriousness, deploy with consumer usability.

The Technology: Intelligent Muscle Activation at Scale

Visionbody is a multi-channel EMS/EMA wearable designed to stimulate most major muscle groups simultaneously through an integrated suit. The system uses programmable “frequency cocktails”—software-defined modulation patterns that target different neuromuscular responses. As Krisztina explains, protocols can be saved in the app so users don’t have to guess: “People don’t have to search for the right frequency. They just simply hit the right program and play the matching program.”

This approach reframes electrostimulation as engineered stimulus delivery rather than a one-size-fits-all shock. The founders emphasize whole-body coordination: strength, posture, and movement are not isolated muscle events, but networked neuromuscular outputs. The latest full-body suit is designed to activate up to 98% of major muscle groups, with coverage that supports both upper and lower body engagement in a single session. The company’s earlier iterations included modular options (e.g., lower-body-focused configurations), but engineering advances consolidated these into a unified platform.

Strength Training as Longevity Infrastructure

A core thesis of Visionbody is that muscle is the currency of longevity. Krisztina frames strength not as aesthetic fitness but as functional biology: “Muscle is the key to longevity. Without muscle… you’re not able to speak, breathe, eat, because these are all muscles.” The founders argue that muscle integrity supports balance, metabolic health, bone density, and recovery capacity—factors that determine whether longer life is lived with independence or decline.

This philosophy is embedded in Visionbody’s design goals: compress meaningful strength stimulus into shorter, repeatable sessions to improve adherence over time. For users constrained by schedules, joint discomfort, or motivation, the system aims to reduce friction while maintaining intensity. The founders are careful to position Visionbody as a complement to movement and lifestyle habits, not a replacement for all exercise, but they contend that neuromuscular activation is foundational—especially as people age.

Rehabilitation, Recovery, and Non-Invasive Wellness

Beyond performance and wellness, VB TECH has invested in rehabilitation-oriented configurations and protocols in collaboration with clinicians. Krisztina points to partnerships with physicians developing programs for pain management and neuropathy, noting that these protocols are stored within the app for ease of use.

The company is also developing adaptations for limited-mobility users, including wraparound suit designs for individuals unable to wear compression garments. Krisztina’s philosophy reflects a broader non-invasive care ethic: “Don’t run immediately to surgery—you can fix so many issues with non-invasive solutions.”

While the company avoids medical claims beyond regulatory scope, their design intent centers on supporting tissue reactivation, neuromuscular engagement, and functional recovery pathways that can complement clinical care.

 

Resilience Through Mission: Personal Stories Inform the Platform

The founders’ commitment to neuromuscular resilience is not abstract. Krisztina recounts how Visionbody-based rehabilitation supported recovery after injury in her own family, reinforcing their belief that structured muscle activation can accelerate functional return. She also shares the emotional weight of building the company through personal health crises, including her husband’s cancer journey and their determination to rebuild strength after aggressive treatments. Visionbody’s rehabilitation edition, she notes, played a role in restoring functional capacity during recovery.

These experiences shape the company’s roadmap toward broader rehab versions and protocols for limited-mobility patients. The founders view neuromuscular stimulation not merely as performance tech, but as infrastructure for resilience when voluntary movement is compromised.

The Future of Wellness: Engineered Adherence, Not Willpower

Looking forward, VB TECH frames the next era of wellness as engineered adherence—systems that make beneficial behaviors easier to sustain. Visionbody’s software-defined protocols, short high-density sessions, and whole-body coverage are designed to lower the activation energy of strength training. In this future, strength becomes a scheduled physiological input rather than a sporadic lifestyle aspiration.

Krisztina is also vocal about the risks of low-quality copycat devices entering the market, warning that poorly engineered electrostimulation can harm users. Her stance is unequivocal: “I would never put a cheap product with electrostimulation on my body because I know how it can hurt.”

This emphasis on certification and protocol integrity is central to VB TECH’s brand positioning: wellness technology should be treated with the seriousness of medical engineering, even when deployed for fitness.

 

Conclusion: Strength as Preventive Medicine

Visionbody’s long-term trajectory is not framed as gadget evolution, but as a shift in how strength is delivered across the lifespan. The founders situate neuromuscular activation within preventive health infrastructure—supporting mobility, metabolic stability, bone density maintenance, and recovery capacity over decades. Their vision is pragmatic and human-centered: longevity without strength is fragile longevity.

As Krisztina summarizes the ethos behind their work, “It’s not just a fancy suit… muscle is the key to longevity.” Visionbody is their attempt to engineer that principle into a scalable, non-invasive platform—bringing strength training closer to where modern wellness is headed: measurable, accessible, and designed for long-range resilience.